<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05020808</url>
  </required_header>
  <id_info>
    <org_study_id>2020_04_07_EHS</org_study_id>
    <nct_id>NCT05020808</nct_id>
  </id_info>
  <brief_title>The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise</brief_title>
  <official_title>The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest, and After Resistance Exercise: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Limerick</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Marigot Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Enterprise Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Limerick</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Plant-based proteins contain several amino acids that are essential to signal growth,&#xD;
      reconditioning, maintenance and preservation of skeletal muscle mass. This study aims to&#xD;
      inform on the nutrient activation of muscle protein synthesis (MPS) by feeding a plant&#xD;
      protein isolate equivalent to 0.33 g of protein per kilogram of body mass.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants: 32 young, healthy men and women aged 18 - 35 years. Intervention: Plant protein&#xD;
      isolate (PPI) and nonessential amino acid control (NEAA) Study Design: Block randomised&#xD;
      control trial. Two group parallel design. Primary outcome: Myofibrillar fractional synthetic&#xD;
      rate (myoFSR).&#xD;
&#xD;
      Preliminary screening/familiarization consists of: medical history, dietary assessment and&#xD;
      examination by a medical doctor and a qualified dietician, blood sample to be evaluated for&#xD;
      health-related contraindications, body composition measurement by dual energy x-ray&#xD;
      absorptiometry (DXA), isokinetic knee extensor strength tests.&#xD;
&#xD;
      Pre-trial: A metered dose of deuterium oxide (5ml/kg) will be ingested and blood and/or&#xD;
      saliva (~5ml) samples will be collected pre/post ingestion.&#xD;
&#xD;
      Experimental trial: Blood, saliva and bilateral m.vastus lateralis microbiopsies (~100 mg)&#xD;
      collected. A unilateral resistance-training session consisting of knee extensor contractions&#xD;
      will be completed. Following exercise cessation participants will ingest 0.33 g/kg body mass&#xD;
      of either: a nonessential amino acid formulation or a plant-protein isolate. A saliva sample&#xD;
      and a 2nd set of bilateral m.vastus lateralis microbiopsies are collected 3 h postingestion.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2021</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Block randomized control trial, parallel group design</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Single blind (participant)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Myofibrillar fractional synthetic rate change</measure>
    <time_frame>4 hours</time_frame>
    <description>The fractional rate of myofibrillar protein synthesis measured by deuterium incorporation into skeletal muscle sampled by microbiopsy</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Metabolism</condition>
  <condition>Exercise</condition>
  <condition>Dietary Supplements</condition>
  <arm_group>
    <arm_group_label>Nonessential amino acid formulation (NEAA)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Novel non-essential amino acid blend dosed at 0.33 g/kg body mass in 400 ml of water. Postprandial muscle protein synthesis at rest, and after resistance exercise to be measured by deuterium incorporation in to skeletal muscle sampled by bilateral microbiopsies.&#xD;
Product Number: NEAA56812</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plant Protein Isolate (PPI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Plant protein isolate (Fava bean) dosed at 0.33 g/kg body mass in 400 ml of water. Postprandial muscle protein synthesis at rest, and after resistance exercise to be measured by deuterium incorporation in to skeletal muscle sampled by bilateral microbiopsies.&#xD;
Product Number: FP2011273</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>NEAA</intervention_name>
    <description>Food grade mixture of non-essential amino acids in powdered form to be dissolved in water. Supplied by Marigot Ltd, Cork, Ireland</description>
    <arm_group_label>Nonessential amino acid formulation (NEAA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PPI</intervention_name>
    <description>Food grade plant (legume - Fava) protein isolate to be dissolved in water. Supplied by Marigot Ltd, Cork, Ireland</description>
    <arm_group_label>Plant Protein Isolate (PPI)</arm_group_label>
    <other_name>Plant Protein Isolate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Men and women aged 18 to 35 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known intolerance to any item contained in the protein products.&#xD;
&#xD;
          -  Blood borne disease risk, current illness or medication that would adversely affect&#xD;
             participation&#xD;
&#xD;
          -  Known adverse reaction to venepuncture and/or biopsy&#xD;
&#xD;
          -  Inability to undertake resistance exercise&#xD;
&#xD;
          -  Inability to adhere to protocol guidelines&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip M Jakeman, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Limerick</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert W Davies, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Limerick</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marta Kozior, PhD</last_name>
    <phone>+353860220542</phone>
    <phone_ext>2800</phone_ext>
    <email>marta.kozior@ul.ie</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert W Davies, PhD</last_name>
    <phone>+35361233203</phone>
    <phone_ext>3203</phone_ext>
    <email>robert.davies@ul.ie</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Limerick</name>
      <address>
        <city>Limerick</city>
        <state>Munster</state>
        <zip>V94 T9PX</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip M Jakeman, PhD</last_name>
      <phone>+35361202800</phone>
      <phone_ext>2800</phone_ext>
      <email>phil.jakeman@ul.ie</email>
    </contact>
    <contact_backup>
      <last_name>Robert W Davies, PhD</last_name>
      <phone>+35361233203</phone>
      <phone_ext>3203</phone_ext>
      <email>robert.davies@ul.ie</email>
    </contact_backup>
    <investigator>
      <last_name>Philip M Jakeman, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert W Davies, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marta Kozior, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 17, 2021</study_first_submitted>
  <study_first_submitted_qc>August 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Limerick</investigator_affiliation>
    <investigator_full_name>Robert Davies</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>amino acids</keyword>
  <keyword>deuterium oxide</keyword>
  <keyword>humans</keyword>
  <keyword>protein synthesis</keyword>
  <keyword>plant proteins</keyword>
  <keyword>resistance training</keyword>
  <keyword>skeletal muscle</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

